Does BELANTAMAB MAFODOTIN Cause Plasma cell myeloma? 380 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 380 reports of Plasma cell myeloma have been filed in association with BELANTAMAB MAFODOTIN (Blenrep). This represents 16.6% of all adverse event reports for BELANTAMAB MAFODOTIN.
380
Reports of Plasma cell myeloma with BELANTAMAB MAFODOTIN
16.6%
of all BELANTAMAB MAFODOTIN reports
191
Deaths
61
Hospitalizations
How Dangerous Is Plasma cell myeloma From BELANTAMAB MAFODOTIN?
Of the 380 reports, 191 (50.3%) resulted in death, 61 (16.1%) required hospitalization, and 10 (2.6%) were considered life-threatening.
Is Plasma cell myeloma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELANTAMAB MAFODOTIN. However, 380 reports have been filed with the FAERS database.
What Other Side Effects Does BELANTAMAB MAFODOTIN Cause?
Keratopathy (788)
Visual acuity reduced (708)
Death (499)
Dry eye (359)
Night blindness (317)
Photophobia (183)
Foreign body sensation in eyes (151)
Vision blurred (134)
Ocular toxicity (94)
Punctate keratitis (91)
What Other Drugs Cause Plasma cell myeloma?
LENALIDOMIDE (14,191)
DEXAMETHASONE (9,207)
POMALIDOMIDE (7,023)
BORTEZOMIB (6,683)
IXAZOMIB (3,249)
DARATUMUMAB (2,980)
CARFILZOMIB (2,238)
CYCLOPHOSPHAMIDE (2,058)
THALIDOMIDE (1,652)
SELINEXOR (1,046)
Which BELANTAMAB MAFODOTIN Alternatives Have Lower Plasma cell myeloma Risk?
BELANTAMAB MAFODOTIN vs BELANTAMAB MAFODOTIN-BLMF
BELANTAMAB MAFODOTIN vs BELATACEPT
BELANTAMAB MAFODOTIN vs BELIMUMAB
BELANTAMAB MAFODOTIN vs BELINOSTAT
BELANTAMAB MAFODOTIN vs BELUMOSUDIL